Clinical Trials Logo

Guillain-Barre Syndrome clinical trials

View clinical trials related to Guillain-Barre Syndrome.

Filter by:

NCT ID: NCT04092140 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

Neuromuscular Ultrasound in Correlation to Neurophysiological Findings

Start date: October 1, 2019
Phase:
Study type: Observational

1. Study the neuromuscular ultrasound findings in different types of neuropathies 2. correlation between ultrasound and neurophysiological findings in peripheral nerve diseases 3. correlation between clinical pain scale and severity of neuropathy

NCT ID: NCT04053452 Terminated - Clinical trials for Guillain-Barre Syndrome

Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome

Start date: September 30, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.

NCT ID: NCT04035135 Completed - Clinical trials for Guillain-Barré Syndrome

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Start date: January 29, 2020
Phase: Phase 1
Study type: Interventional

This study is a multi center, open-label, study of ANX005 in combination with IVIg in subjects diagnosed with GBS.

NCT ID: NCT03943589 Completed - Clinical trials for Guillain-Barré Syndrome (GBS)

A Study of Imlifidase in Patients With Guillain-Barré Syndrome

Start date: November 12, 2019
Phase: Phase 2
Study type: Interventional

The study participants are patients which have been diagnosed with Guillain-Barré Syndrome (GBS) and are planned to receive treatment with intravenous immunoglobulin (IVIg). IVIg is a standard of care treatment for GBS patients. The patients in this study will be treated with the study medicine imlifidase on day 1, and with IVIg on days 3-7. The purpose of this study is to investigate the safety and effectiveness of imlifidase in patients diagnosed with GBS.

NCT ID: NCT03941184 Completed - Clinical trials for Rheumatoid Arthritis

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Start date: January 1, 1995
Phase:
Study type: Observational

This case control study aims to determine whether spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and to update the incidence of SCAD in a population-based cohort.

NCT ID: NCT03840928 Recruiting - Obesity Clinical Trials

PatientSpot Formerly Known as ArthritisPower

Start date: April 1, 2015
Phase:
Study type: Observational [Patient Registry]

Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness to participate in research from participants with rheumatoid arthritis (RA), spondyloarthritis (SpA), other musculoskeletal conditions, chronic neurological conditions like migraine, chronic pulmonary conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, autoimmune dermatological conditions such as psoriasis, and other chronic inflammatory or immune-mediated conditions. In addition, since patients with chronic conditions often have other co-morbidities like cardiovascular health and obesity-related metabolic disorders, these conditions will also be included. Participants will provide information from their smartphones or personal computers. The information will be used by researchers and clinicians to help patients and their providers make better, more informed decisions about treatment of chronic conditions.

NCT ID: NCT03826056 Completed - Multiple Sclerosis Clinical Trials

Neurology Inpatient Clinical Education Trial

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores. The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.

NCT ID: NCT03801135 Recruiting - Clinical trials for Guillain-Barre Syndrome

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Start date: October 3, 2018
Phase: N/A
Study type: Interventional

Plasma exchange procedures remove procoagulant and anticoagulant factors. Every procedure increases the risk of bleeding and repeated procedures increase the risk of bleeding mostly because lower fibrinogen levels. The aim of study is to define coagulation status of patient after plasmapheresis with different laboratory tests and to investigate the possibility of fibrinogen concentrate replacement for the correction of induced coagulation disorder.

NCT ID: NCT03773328 Withdrawn - Clinical trials for Guillain-Barré Syndrome

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-BarreĢ Syndrome (GBS)

Start date: November 2022
Phase: Phase 1
Study type: Interventional

The goal of this research study is to determine whether it is safe and practical to give CK0801 (a cord-blood derived T-regulatory cell product) to patients with Guillain-Barré Syndrome (GBS). Researchers also want to determine the highest possible dose that is safe to be given and to learn if CK0801 may improve the symptoms of GBS. There will be three doses of CK0801 given during this study. A minimum of three patients will be treated in each dose level. The dose a patient receives is dependent on the timing of when they enter the study, as after each dose level is completed the following patients will receive the next highest dose level.

NCT ID: NCT03710278 Completed - Clinical trials for Subarachnoid Hemorrhage

The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)

LPat
Start date: December 21, 2017
Phase:
Study type: Observational

The purpose of this study is to proof and investigate the effectiveness and safety of the invented device named "Human Lumbar Puncture Assist Device (LPat)" as an assist tool to be utilized to improve the success rate of performing lumbar puncture (LP), avoid side effects from multiple punctures, avoid excess radiation if the LP need to be done under fluoroscopy, and need to obtain none traumatic tap for better CSF analysis.